Arrail Group Past Earnings Performance
Past criteria checks 2/6
Arrail Group has been growing earnings at an average annual rate of 52%, while the Healthcare industry saw earnings growing at 9% annually. Revenues have been growing at an average rate of 2.8% per year. Arrail Group's return on equity is 0.6%, and it has net margins of 1.2%.
Key information
52.0%
Earnings growth rate
69.9%
EPS growth rate
| Healthcare Industry Growth | 11.3% |
| Revenue growth rate | 2.8% |
| Return on equity | 0.6% |
| Net Margin | 1.2% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Investors Shouldn't Be Too Comfortable With Arrail Group's (HKG:6639) Earnings
Dec 31
Even With A 41% Surge, Cautious Investors Are Not Rewarding Arrail Group Limited's (HKG:6639) Performance Completely
Oct 02Arrail Group (HKG:6639) Seems To Use Debt Quite Sensibly
Sep 02Arrail Group Limited's (HKG:6639) Share Price Is Still Matching Investor Opinion Despite 28% Slump
Jul 15Is Arrail Group (HKG:6639) A Risky Investment?
Feb 27The Price Is Right For Arrail Group Limited (HKG:6639) Even After Diving 28%
Aug 23Arrail Group Limited Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next
Jul 02Are Investors Undervaluing Arrail Group Limited (HKG:6639) By 39%?
May 18Are Investors Undervaluing Arrail Group Limited (HKG:6639) By 28%?
Feb 01Are Investors Undervaluing Arrail Group Limited (HKG:6639) By 24%?
Jun 30Revenue & Expenses Breakdown
How Arrail Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 1,747 | 21 | 355 | 8 |
| 30 Jun 24 | 1,746 | 19 | 369 | 8 |
| 31 Mar 24 | 1,746 | 17 | 383 | 8 |
| 31 Dec 23 | 1,667 | -55 | 392 | 10 |
| 30 Sep 23 | 1,588 | -126 | 402 | 12 |
| 30 Jun 23 | 1,531 | -173 | 420 | 15 |
| 31 Mar 23 | 1,474 | -220 | 439 | 19 |
| 31 Dec 22 | 1,514 | -271 | 441 | 26 |
| 30 Sep 22 | 1,554 | -321 | 442 | 33 |
| 30 Jun 22 | 1,589 | -511 | 399 | 33 |
| 31 Mar 22 | 1,624 | -701 | 356 | 33 |
| 31 Dec 21 | 1,630 | -790 | 300 | 31 |
| 30 Sep 21 | 1,636 | -878 | 244 | 29 |
| 30 Jun 21 | 1,576 | -739 | 228 | 28 |
| 31 Mar 21 | 1,515 | -599 | 212 | 27 |
| 31 Mar 20 | 1,100 | -317 | 202 | 27 |
| 31 Mar 19 | 1,080 | -301 | 211 | 19 |
Quality Earnings: 6639 has a large one-off gain of CN¥23.0M impacting its last 12 months of financial results to 30th September, 2024.
Growing Profit Margin: 6639 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 6639 has become profitable over the past 5 years, growing earnings by 52% per year.
Accelerating Growth: 6639 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 6639 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (-16.9%).
Return on Equity
High ROE: 6639's Return on Equity (0.6%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/03 17:07 |
| End of Day Share Price | 2025/01/03 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Arrail Group Limited is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yanyin Zhu | China International Capital Corporation Limited |
| Youjue Hu | Morgan Stanley |